RESUMEN
OBJECTIVE: The etiology of oral verrucous carcinoma is unknown, and human papillomavirus 'involvement' remains contentious. The uncertainty can be attributed to varied detection procedures and difficulties in defining 'gold-standard' histologic criteria for diagnosing 'verrucous' lesions. Their paucity also hampers investigation. We aimed to analyze oral verrucous lesions for human papillomavirus (HPV) subtype genomes. STUDY DESIGN: We used next-generation sequencing for the detection of papillomavirus sequences, identifying subtypes and computing viral loads. We identified a total of 78 oral verrucous cases (62 carcinomas and 16 hyperplasias). DNA was extracted from all and sequenced at a coverage between 2.5% and 13%. RESULTS: An HPV-16 sequence was detected in 1 carcinoma and 1 hyperplasia, and an HPV-2 sequence was detected in 1 carcinoma out of the 78 cases, with viral loads of 2.24, 8.16, and 0.33 viral genomes per cell, respectively. CONCLUSIONS: Our results indicate no conclusive human papillomavirus involvement in oral verrucous carcinoma or hyperplasia.
Asunto(s)
Carcinoma Verrugoso/virología , Neoplasias de la Boca/virología , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/virología , Análisis de Secuencia de ADN/métodos , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Verrugoso/genética , Femenino , Infecciones por Herpesviridae/genética , Infecciones por Herpesviridae/virología , Papillomavirus Humano 16/genética , Papillomavirus Humano 16/aislamiento & purificación , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/genética , Papillomaviridae/genética , Infecciones por Papillomavirus/genética , Carga ViralRESUMEN
HHARI (also known as ARIH1) is an ubiquitin-protein ligase and is the cognate of the E2, UbcH7 (UBE2L3). To establish a functional role for HHARI in cellular proliferation processes, we performed a reverse genetics screen that identified n=86/522 (16.5%) ubiquitin conjugation components that have a statistically significant effect on cell proliferation, which included HHARI as a strong hit. We then produced and validated a panel of specific antibodies that establish HHARI as both a nuclear and cytoplasmic protein that is expressed in all cell types studied. HHARI was expressed at higher levels in nuclei, and co-localized with nuclear bodies including Cajal bodies (p80 coilin, NOPP140), PML and SC35 bodies. We confirmed reduced cellular proliferation after ARIH1 knockdown with individual siRNA duplexes, in addition to significantly increased levels of apoptosis, an increased proportion of cells in G2 phase of the cell cycle, and significant reductions in total cellular RNA levels. In head and neck squamous cell carcinoma biopsies, there are higher levels of HHARI expression associated with increased levels of proliferation, compared to healthy control tissues. We demonstrate that HHARI is associated with cellular proliferation, which may be mediated through its interaction with UbcH7 and modification of proteins in nuclear bodies.
Asunto(s)
Biomarcadores , Proteínas Portadoras/metabolismo , Proteínas Portadoras/fisiología , Proliferación Celular , Cuerpos Enrollados/metabolismo , Animales , Biomarcadores/metabolismo , Proteínas Portadoras/genética , Núcleo Celular/metabolismo , Núcleo Celular/fisiología , Núcleo Celular/ultraestructura , Células Cultivadas , Cuerpos Enrollados/fisiología , Drosophila/genética , Proteínas de Drosophila/genética , Células HEK293 , Células HeLa , Humanos , Ratones , Unión Proteica , Homología de Secuencia , Ubiquitina-Proteína LigasasRESUMEN
BACKGROUND: Non-setting calcium hydroxide (Ultracal XS(®) ) is recommended by the International Association of Dental Traumatology as the initial medicament following avulsion and replantation for mature teeth. There is experimental evidence to suggest Ledermix(®) , placed as an alternative inter-visit dressing may improve periodontal healing. AIM: This study investigated, using a multi-centre randomized controlled trial, the effect of two root canal medicaments, Ledermix(®) and Ultracal XS(®) , on periodontal healing of avulsed and replanted teeth. MATERIAL AND METHODS: Children were recruited if they fulfilled all inclusion criteria. Treatment followed a standardized protocol. Assessment of periodontal healing or ankylosis was made clinically and radiographically by an experienced, 'blinded', clinician at 12months. RESULTS: Over 200 patients were assessed for eligibility at five centres. Twenty-nine patients were eligible for inclusion. Final analysis involved 22 patients with 27 teeth. Ankylosis was detected in four of the 12 teeth in the Ledermix(®) group and nine of 15 in the Ultracal XS(®) group. No significant difference between medicaments was found in the proportion of teeth or patients showing periodontal healing. DISCUSSION: There was no significant difference in periodontal healing between the two medicaments at either a tooth or patient level. The numbers recruited fell short of an estimated power calculation. For patients meeting the inclusion criteria and completing the trial, periodontal healing was seen in 52% of teeth at the 12-month assessment between both groups. The only factor found to significantly influence the periodontal outcome was dry time.
Asunto(s)
Ligamento Periodontal/fisiopatología , Irrigantes del Conducto Radicular/uso terapéutico , Avulsión de Diente/terapia , Reimplante Dental/métodos , Adolescente , Hidróxido de Calcio/uso terapéutico , Niño , Demeclociclina/uso terapéutico , Combinación de Medicamentos , Femenino , Estudios de Seguimiento , Humanos , Masculino , Tratamiento del Conducto Radicular/métodos , Resorción Radicular/prevención & control , Método Simple Ciego , Anquilosis del Diente/prevención & control , Resultado del Tratamiento , Triamcinolona Acetonida/uso terapéutico , Cicatrización de Heridas/fisiologíaRESUMEN
INTRODUCTION: There is evidence to suggest that Ledermix, placed as an intervisit root canal dressing, might improve periodontal healing after replantation of avulsed teeth. As a part of a multicenter randomized controlled trial, we aimed to compare the effect of 2 root canal medicaments, Ledermix and Ultracal XS, on the discoloration of replanted teeth. METHODS: Discoloration was investigated by using 3 methods: patient satisfaction with the color of replanted teeth, clinical photographs taken at baseline and 12-month reviews, and estimation of color change by using CIELAB scores for baseline and 12-month photographs. RESULTS: Twenty-two patients (27 teeth) were recruited. Ten patients (12 teeth) were randomized to the Ledermix group and 12 patients (15 teeth) to the Ultracal XS group. At 12 months, 8 patients were concerned with the discoloration of their teeth. Seven came from the Ledermix group and 1 from the Ultracal XS group. This difference was significant (Fisher exact test, P = .009). Standardized photographs were taken for the patients recruited at one center only (17 patients). There was significant discoloration of teeth from baseline with Ledermix, causing a darkening and gray-brown discoloration (mean change from baseline to 12 months, L∗ = -5.1, a∗ = 0.3, b∗ = -1.2, and ΔE = 8.1) and Ultracal XS, causing a yellowing and lightening of teeth (L∗ = 1.9, a∗ = 0.3, b∗ = 3.3, and ΔE = 5.4). There was a significant difference for the L∗ and b∗ variables (independent t test) between the 2 groups. CONCLUSIONS: Both root canal medicaments cause discoloration, with Ledermix proving less acceptable to patients.
Asunto(s)
Irrigantes del Conducto Radicular/efectos adversos , Avulsión de Diente/cirugía , Decoloración de Dientes/inducido químicamente , Reimplante Dental , Hidróxido de Calcio/efectos adversos , Distribución de Chi-Cuadrado , Colorimetría , Demeclociclina/efectos adversos , Combinación de Medicamentos , Humanos , Satisfacción del Paciente , Fotografía Dental , Tratamiento del Conducto Radicular/efectos adversos , Estadísticas no Paramétricas , Triamcinolona Acetonida/efectos adversosRESUMEN
In recent years there has been much interest in the use of optical diagnostics in cancer detection. Early diagnosis of cancer affords early intervention and greatest chance of cure. Raman spectroscopy is based on the interaction of photons with the target material producing a highly detailed biochemical 'fingerprint' of the sample. It can be appreciated that such a sensitive biochemical detection system could confer diagnostic benefit in a clinical setting. Raman has been used successfully in key health areas such as cardiovascular diseases, and dental care but there is a paucity of literature on Raman spectroscopy in Head and Neck cancer. Following the introduction of health care targets for cancer, and with an ever-aging population the need for rapid cancer detection has never been greater. Raman spectroscopy could confer great patient benefit with early, rapid and accurate diagnosis. This technique is almost labour free without the need for sample preparation. It could reduce the need for whole pathological specimen examination, in theatre it could help to determine margin status, and finally peripheral blood diagnosis may be an achievable target.
Asunto(s)
Carcinoma de Células Escamosas/diagnóstico , Neoplasias de Cabeza y Cuello/diagnóstico , Espectrometría Raman/métodos , Carcinoma/diagnóstico , Carcinoma/patología , Carcinoma de Células Escamosas/patología , Detección Precoz del Cáncer/métodos , Neoplasias de Cabeza y Cuello/patología , Humanos , Neoplasias de Células Escamosas/diagnóstico , Neoplasias de Células Escamosas/patología , Carcinoma de Células Escamosas de Cabeza y Cuello , Células Tumorales CultivadasRESUMEN
Long PLUNC1 (LPLUNC1, C20orf114) is a member of a family of poorly described proteins (PLUNCS) expressed in the upper respiratory tract and oral cavity, which may function in host defence. Although it is one of the most highly expressed genes in the upper airways and has been identified in sputum and nasal secretions by proteomic studies, localisation of LPLUNC1 protein has not yet been described. We developed affinity purified antibodies and localised the protein in tissues of the human respiratory tract, oro- and nasopharynx. We have complemented these studies with analysis of LPLUNC1 expression in primary human lung cell cultures and used Western blotting to study the protein in cell culture secretions and in BAL. LPLUNC1 is a product of a population of goblet cells in the airway epithelium and nasal passages and is also present in airway submucosal glands and minor glands of the oral and nasal cavities. The protein is not expressed in peripheral lung epithelial cells. LPLUNC1 is present in bronchoalveolar lavage fluid as two glycosylated isoforms and primary airway epithelial cells produce identical proteins as they undergo mucociliary differentiation. Our results suggest that LPLUNC1 is an abundant, secreted product of goblet cells and minor mucosal glands of the respiratory tract and oral cavity and suggest that the protein functions in the complex milieu that protects the mucosal surfaces in these locations.
Asunto(s)
Glándulas Exocrinas/metabolismo , Glicoproteínas/metabolismo , Células Caliciformes/metabolismo , Boca/metabolismo , Fosfoproteínas/metabolismo , Sistema Respiratorio/metabolismo , Anticuerpos/inmunología , Líquido del Lavado Bronquioalveolar/química , Diferenciación Celular/fisiología , Células Cultivadas , Elafina/genética , Células Epiteliales/citología , Células Epiteliales/metabolismo , Expresión Génica/genética , Glicoproteínas/análisis , Glicoproteínas/genética , Glicoproteínas/inmunología , Glicosilación , Humanos , Mucina 5AC/metabolismo , Tonsila Palatina/metabolismo , Fosfoproteínas/análisis , Fosfoproteínas/genética , Fosfoproteínas/inmunología , Mucosa Respiratoria/citología , Mucosa Respiratoria/metabolismo , Inhibidor Secretorio de Peptidasas Leucocitarias/genética , Lengua/metabolismo , Uteroglobina/genéticaRESUMEN
Raman spectroscopy could offer non-invasive, rapid and an objective nature to cancer diagnostics. However, much work in this field has focused on resolving differences between cancerous and non-cancerous tissues, and lacks the reproducibility and interpretation to be put into clinical practice. Much work is needed on basic cellular differences between malignancy and normal. This would allow the establishment of a clinically relevant cellular based model to translate to tissue classification. Raman spectroscopy provides a very detailed biochemical analysis of the target material and to 'unlock' this potential requires sophisticated mathematical modelling such as neural networks as an adjunct to data interpretation. Commercially obtained cancerous and non-cancerous cells, cultured in the laboratory were used in Raman spectral measurements. Data trends were visualised through PCA and then subjected to neural network analysis based on self-organising maps; consisting of m maps, where m is the number of classes to be recognised. Each map approximates the statistical distribution of a given class. The neural network analysis provided a 95% accuracy for identification of the cancerous cell line and 92% accuracy for normal cell line. In this preliminary study we have demonstrated th ability to distinguish between "normal" and cancerous commercial cell lines. This encourages future work to establish the reasons underpinning these spectral differences and to move forward to more complex systems involving tissues. We have also shown that the use of sophisticated mathematical modelling allows a high degree of discrimination of 'raw' spectral data.
Asunto(s)
Redes Neurales de la Computación , Espectrometría Raman/métodos , Glándula Tiroides/citología , Neoplasias de la Tiroides/patología , Línea Celular , Humanos , Modelos Teóricos , Análisis de Componente PrincipalRESUMEN
Cancer poses a massive health burden with incidence rates expected to double globally over the next decade. In the United Kingdom screening programmes exists for cervical, breast, and colorectal cancer. The ability to screen individuals for solid malignant tumours using only a peripheral blood sample would revolutionise cancer services and permit early diagnosis and intervention. Raman spectroscopy interrogates native biochemistry through the interaction of light with matter, producing a high definition biochemical 'fingerprint' of the target material. This paper explores the possibility of using Raman spectroscopy to discriminate between cancer and non-cancer patients through a peripheral blood sample. Forty blood samples were obtained from patients with Head and Neck cancer and patients with respiratory illnesses to act as a positive control. Raman spectroscopy was carried out on all samples with the resulting spectra being used to build a classifier in order to distinguish between the cancer and respiratory patients' spectra; firstly using principal component analysis (PCA)/linear discriminant analysis (LDA), and secondly with a genetic evolutionary algorithm. The PCA/LDA classifier gave a 65% sensitivity and specificity for discrimination between the cancer and respiratory groups. A sensitivity score of 75% with a specificity of 75% was achieved with a 'trained' evolutionary algorithm. In conclusion this preliminary study has demonstrated the feasibility of using Raman spectroscopy in cancer screening and diagnostics of solid tumours through a peripheral blood sample. Further work needs to be carried out for this technique to be implemented in the clinical setting.
Asunto(s)
Detección Precoz del Cáncer/métodos , Neoplasias/diagnóstico , Espectrometría Raman/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/sangre , Análisis de Componente PrincipalRESUMEN
We recently described the Palate Lung Nasal Clone (PLUNC) family of proteins as an extended group of proteins expressed in the upper airways, nose and mouth. Little is known about these proteins, but they are secreted into the airway and nasal lining fluids and saliva where, due to their structural similarity with lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein, they may play a role in the innate immune defence. We now describe the generation and characterisation of novel affinity-purified antibodies to SPLUNC2, and use them to determine the expression of this, the major salivary gland PLUNC. Western blotting showed that the antibodies identified a number of distinct protein bands in saliva, whilst immunohistochemical analysis demonstrated protein expression in serous cells of the major salivary glands and in the ductal lumens as well as in cells of minor mucosal glands. Antibodies directed against distinct epitopes of the protein yielded different staining patterns in both minor and major salivary glands. Using RT-PCR of tissues from the oral cavity, coupled with EST analysis, we showed that the gene undergoes alternative splicing using two 5' non-coding exons, suggesting that the gene is regulated by alternative promoters. Comprehensive RACE analysis using salivary gland RNA as template failed to identify any additional exons. Analysis of saliva showed that SPLUNC2 is subject to N-glycosylation. Thus, our study shows that multiple SPLUNC2 isoforms are found in the oral cavity and suggest that these proteins may be differentially regulated in distinct tissues where they may function in the innate immune response.
Asunto(s)
Empalme Alternativo , Glicoproteínas/fisiología , Fosfoproteínas/fisiología , Proteínas y Péptidos Salivales/fisiología , Secuencia de Aminoácidos , Animales , Glicoproteínas/genética , Humanos , Datos de Secuencia Molecular , Especificidad de Órganos , Glándula Parótida/metabolismo , Fosfoproteínas/genética , Saliva/metabolismo , Glándulas Salivales/metabolismo , Proteínas y Péptidos Salivales/genéticaRESUMEN
Non-destructive methods, such as the ac-impedance technique, have recently been applied to early caries detection and to identify micro-leakage between tooth structure and filling materials. However, in vitro impedance measurements are affected by a number of external factors. The purpose of present study was to investigate the effect of the age of teeth on impedance measurements of human dentine by employing electrical impedance spectroscopy (EIS). Fully hydrated dentine samples were prepared from extracted third molars of 20 and 50 year old patients. Ac-impedance measurements were carried out over a wide frequency range. Impedance measurements showed that there were differences in impedance between young and older dentine. In their circuit models, both resistance and capacitance were found to be significantly different (p < 0.05) for the two age groups. One of the age-related changes in dentine is the formation of peritubular dentine on the inner walls of dentinal tubules and we propose that this is responsible for the differences in impedance. Sample or patient age therefore must be considered when making impedance measurements on any tooth.
Asunto(s)
Envejecimiento/fisiología , Dentina/fisiología , Análisis Espectral/métodos , Dentina/química , Dentina/ultraestructura , Impedancia Eléctrica , Humanos , Factores de TiempoRESUMEN
BACKGROUND: The Whey Acidic Protein domain is an evolutionarily conserved motif found in a number of proteins, the best studied of which are antiproteinases involved in the innate immune defence of multiple epithelia. We recently characterised the WFDC2 gene which encodes a two WAP domain-containing protein, initially suggested as a marker for epididymis, and showed that it is highly expressed in the lung and salivary gland. The precise location of WFDC2 protein in these sites has not been described. METHODS: We used immunohistochemistry to localise WFDC2 in normal tissues of the respiratory tract, naso- and oropharynx, as well as in chronically inflamed lung from Cystic Fibrosis and a range of pulmonary carcinomas. We have complemented these studies with molecular analysis of WFDC2 gene expression in primary human lung cell cultures. RESULTS: WFDC2 is expressed in some epithelial cells of the upper airways as well as in mucous cells and ducts of submucosal glands. No staining was seen in peripheral lung. Intense staining is found in major salivary glands and in minor glands of the nose, sinuses, posterior tongue and tonsil. Studies with the related protein Secretory Leukocyte Protease Inhibitor (SLPI) show that although both proteins are expressed in similar tissues, the precise cellular localisation differs. Significant increases in expression and localisation of WFDC2 are seen in patients with Cystic Fibrosis. SLPI expression was greatly reduced in the same samples. In cultures of tracheobronchial epithelial cells, expression of WFDC2 and SLPI are differentially regulated during differentiation yet WFDC2 is not induced by pro-inflammatory mediators. The majority of adenocarcinomas stain with WFDC2 whilst a significant minority of squamous, small cell and large cell carcinomas exhibit focal staining. There is no clear association with tumour grade. CONCLUSION: We believe that these studies support the hypothesis that WFDC2 may be a component of the innate immune defences of the lung, nasal and oral cavities and suggest that WFDC2 functions in concert with related WAP domain containing proteins in epithelial host defence. We also suggest that WFDC2 re-expression in lung carcinomas may prove to be associated with tumour type and should be studied in further detail.
Asunto(s)
Adenocarcinoma/inmunología , Proteínas Secretorias del Epidídimo/fisiología , Neoplasias Pulmonares/inmunología , Boca/inmunología , Proteínas/fisiología , Sistema Respiratorio/inmunología , Adenocarcinoma/metabolismo , Biomarcadores de Tumor/inmunología , Línea Celular Tumoral , Células Cultivadas , Proteínas Secretorias del Epidídimo/biosíntesis , Femenino , Humanos , Inmunidad Innata , Neoplasias Pulmonares/metabolismo , Masculino , Proteínas/inmunología , Sistema Respiratorio/patología , Proteína 2 de Dominio del Núcleo de Cuatro Disulfuros WAPRESUMEN
OBJECTIVES: To identify histological features that distinguish amalgam-associated oral lichenoid reactions (AAOLR) from oral lichen planus (OLP). METHODS: Oral pathologists provided their opinion as to the possibility of distinguishing AAOLR and OLP histologically, the features important in distinguishing AAOLR from OLP and the diagnosis of 12 AAOLR and 12 OLP cases including the features that drew them to their conclusion. RESULTS: There was considerable variation between pathologists in their ability to distinguish the AAOLR and OLP cases. The sensitivity and specificity for histological diagnosis were 40% and 32% respectively. There were four features that were used most commonly to discriminate between AAOLR and OLP: an inflammatory infiltrate located deep to superficial infiltrate in some or all areas; a focal perivascular infiltrate; plasma cells in the connective tissue and neutrophils in the connective tissue. Each was independently predictive of AAOLR or OLP (P < 0.028). CONCLUSIONS: This study confirms the uncertainty of the diagnostic histological differences between AAOLR and OLP. Distinguishing these conditions should not rely on histology alone, but should be based on a synthesis of all available information including history, examination, histopathology and skin patch testing.
Asunto(s)
Amalgama Dental/efectos adversos , Erupciones Liquenoides/patología , Tejido Conectivo/patología , Consenso , Diagnóstico Diferencial , Humanos , Liquen Plano Oral/patología , Erupciones Liquenoides/inducido químicamente , Sensibilidad y EspecificidadRESUMEN
Short PLUNC1 (SPLUNC1) is the founding member of a novel family of proteins (PLUNC) expressed in the upper respiratory tract that may function in host defence. It is one of the most highly expressed genes in the upper airways and the protein has been detected in sputum and nasal secretions. This study describes, for the first time, the precise cellular localization of SPLUNC1 in human tissues from the respiratory tract. Although SPLUNC1 is found in some epithelial cells of the upper airways and coats the surface epithelial cell lining of the major airways, the most significant site of protein localization is in mucous cells and ducts of submucosal glands. Intense staining is also seen in minor glands of the nose, sinuses, posterior tongue and tonsil, suggesting that the protein is secreted into mucoid secretions of these tissues, where it probably functions in host defence. No staining was seen in peripheral lung tissue. As SPLUNC1 has been suggested to be a novel lung cancer marker, a limited panel of lung cancers was also studied. The findings suggest that SPLUNC1 is commonly expressed in adenocarcinomas, muco-epidermoid carcinoma, and bronchio-alveloar carcinoma, and is absent from small-cell carcinoma and squamous cell carcinoma. This expression pattern is consistent with the presumed phenotypic origin of these tumours and suggests that SPLUNC1 may be a useful marker for lung cancer.
Asunto(s)
Glicoproteínas/análisis , Neoplasias Pulmonares/química , Fosfoproteínas/análisis , Sistema Respiratorio/química , Especificidad de Anticuerpos , Biomarcadores de Tumor/análisis , Células Epiteliales/química , Células Epiteliales/inmunología , Humanos , Inmunidad Innata/inmunología , Inmunohistoquímica/métodos , Neoplasias Pulmonares/inmunología , Mucosa Nasal/química , Mucosa Nasal/inmunología , Tonsila Palatina/química , Tonsila Palatina/inmunología , Fenotipo , Mucosa Respiratoria/química , Mucosa Respiratoria/inmunología , Sistema Respiratorio/inmunología , Lengua/química , Lengua/inmunologíaRESUMEN
OBJECTIVE: To analyse smear layers on human dentine using ac-impedance spectroscopy. METHODS: Dentine samples were prepared from extracted, sound, third molars. Impedance measurements were carried out on dentine samples before and after etching. After measuring, samples were examined under scanning electron microscope (SEM) to correlate electrical measurements with structure. RESULTS: Marked differences in impedance before and after etching were demonstrated. SEM investigation showed that a smear layer overlies dentine surfaces before etching, but completely disappeared after etching, leaving open dentinal tubules. CONCLUSIONS: The clinical removal of smear layers is still subjective. This objective method, based on combined ac-impedance and admittance measurement in vitro, has the potential to allow development of standardised techniques and if developed further may be of use in vivo.
Asunto(s)
Dentina/ultraestructura , Capa de Barro Dentinario , Grabado Ácido Dental , Adulto , Dentina/química , Impedancia Eléctrica , Humanos , Microscopía Electrónica de Rastreo , Análisis EspectralRESUMEN
In 1960, Robert James Gorlin and William Goltz, both American physicians, defined a new syndrome. Little did they realize that 40 years later, the pathways involved in its development would be provoking serious and sustained interest amongst a plethora of specialists. Fruit-fly biologists, oncologists, geneticists, dermatologists, indeed, hardly a medical or dental specialist gets excluded. To date, there have been some major breakthroughs in identifying abnormal gene sequences. Much has been discovered about this syndrome and its pivotal role in a number of cancer pathways but much more waits to be done or explained. This article sets out to discuss the current position and aims to stimulate further work on this intriguing and puzzling disorder.